Live
- Cong outdated: Rajnath
- Congress strategy to outwit BJP in North Telangana
- Festival of Demiocracy: 62% turnout in phase 1
- MyVoice: Views of our readers 20th April 2024
- Is US Prez weighing climate emergency declaration soon
- ‘AP people’ve made up their mind on double engine govt’
- Kakinada: Overwhelmed by Godavari love said CM YS Jagan Mohan Reddy
- Caught unawares: Dubai must brace for future storms
- DEO suspends teacher accused of sexual assault
- PM ‘cursing’ Congress out of despair: Maharashtra Cong Chief
Laurus Labs Vizag unit completes USFDA inspection
Highlights
Drug firm Laurus Labs on Friday said audit of its unit 4 at Visakhapatnam in Andhra Pradesh by the US health regulator has been completed without any observations.
New Delhi: Drug firm Laurus Labs on Friday said audit of its unit 4 at Visakhapatnam in Andhra Pradesh by the US health regulator has been completed without any observations.
"The inspection of the unit 4 was carried out from July 8 - 12, 2019," Laurus Labs said in a filing to BSE.
The maiden United States Food and Drug Administration (USFDA) audit for the unit was successfully completed without any observations and no Form 483 was issued, it added.
As per the USFDA, Form 483 notifies the company's management of objectionable conditions.
Next Story
ADVERTISEMENT
